Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1865-8652
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives ; day:11 ; month:2 ; year:2019 ; pages:1-25
Advances in therapy ; (11.2.2019), 1-25
- Creator
-
Rhee, Chin Kook
Yoshisue, Hajime
Lad, Rahul
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12325-019-0893-3
- URN
-
urn:nbn:de:101:1-2019031321174078309104
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Rhee, Chin Kook
- Yoshisue, Hajime
- Lad, Rahul
- SpringerLink (Online service)
Other Objects (12)
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Long-Acting Reversible Contraception
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
Fabrication of Electrospun Levodopa-Carbidopa Fixed-Dose Combinations
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
Creation of a long-acting nanoformulated dolutegravir
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Long-Acting Reversible Contraception
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
Fabrication of Electrospun Levodopa-Carbidopa Fixed-Dose Combinations
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
Creation of a long-acting nanoformulated dolutegravir
Long-acting injectable atovaquone nanomedicines for malaria prophylaxis
A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β2-Agonist (LABA) Combinations in COPD
A randomized controlled trial of long-acting muscarinic antagonist and long-acting β2 agonist fixed-dose combinations in patients with chronic obstructive pulmonary disease
Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids
Long-Acting Reversible Contraception
Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
Practical considerations when prescribing a long-acting muscarinic antagonist for patients with COPD
Fabrication of Electrospun Levodopa-Carbidopa Fixed-Dose Combinations
Long-acting olanzapine versus long-acting risperidone for schizophrenia in Spain – a cost-effectiveness comparison
Development of long-acting ARV’s
Long-acting bronchodilators improve exercise capacity in COPD patients: a systematic review and meta-analysis
Creation of a long-acting nanoformulated dolutegravir